2008
DOI: 10.1097/00042728-200807000-00001
|View full text |Cite
|
Sign up to set email alerts
|

Nonsurgical Treatment Modalities for Primary Cutaneous Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
3
0
3

Year Published

2011
2011
2013
2013

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 76 publications
0
3
0
3
Order By: Relevance
“…Given the fact that skin tumors are among the most common type of tumors, accounting for more than one out of three new tumors, development of effective and safe treatment alternatives for this malady is warranted 1,2. Topical, self‐administered treatment is in many instances preferred over more destructive therapies for providing less risk of pain, ulceration, and residual scarring 3. Examples of these instances include superficial and diffuse nonmelanoma tumors and when the patient is a poor surgical candidate due to, for example, tendency to develop keloids 3.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Given the fact that skin tumors are among the most common type of tumors, accounting for more than one out of three new tumors, development of effective and safe treatment alternatives for this malady is warranted 1,2. Topical, self‐administered treatment is in many instances preferred over more destructive therapies for providing less risk of pain, ulceration, and residual scarring 3. Examples of these instances include superficial and diffuse nonmelanoma tumors and when the patient is a poor surgical candidate due to, for example, tendency to develop keloids 3.…”
Section: Introductionmentioning
confidence: 99%
“…Topical, self‐administered treatment is in many instances preferred over more destructive therapies for providing less risk of pain, ulceration, and residual scarring 3. Examples of these instances include superficial and diffuse nonmelanoma tumors and when the patient is a poor surgical candidate due to, for example, tendency to develop keloids 3. In this study, we evaluated the potential of nanostructured systems containing a protein transduction domain (PTD) to deliver a highly effective anticancer agent, paclitaxel.…”
Section: Introductionmentioning
confidence: 99%
“…1 New investigative treatments include immunotherapy and gene therapy. Factors that influence the choice of treatment are the site, grade, and stage of the primary tumor, patient age, and general medical condition.…”
Section: Introductionmentioning
confidence: 99%
“…As opções de tratamento do câncer de pele existentes atualmente podem ser divididas em alternativas cirúrgicas e não-cirúrgicas, que incluem os tratamentos farmacológicos, sendo que a escolha depende de alguns fatores (tabela 1) como o tipo de câncer e o estágio das lesões [15]. A remoção cirúrgica é a forma convencional de tratamento, com taxas de cura muito elevadas [15].…”
Section: Introductionunclassified
“…As opções de tratamento do câncer de pele existentes atualmente podem ser divididas em alternativas cirúrgicas e não-cirúrgicas, que incluem os tratamentos farmacológicos, sendo que a escolha depende de alguns fatores (tabela 1) como o tipo de câncer e o estágio das lesões [15]. A remoção cirúrgica é a forma convencional de tratamento, com taxas de cura muito elevadas [15]. No entanto, tratamentos farmacológicos são recomendados para tumores do tipo não-melanoma em diversas situações, como em lesões superficiais e difusas, de difícil acesso e/ou para pacientes que não são considerados bons candidato à cirurgia, o que inclui pacientes de idade avançada e aqueles que apresentam tendência à formação de queloides [15].…”
Section: Introductionunclassified